Home > Insider Trading > Filing (0001181431-11-038524)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1389870	Omni Bio Pharmaceutical Inc.	OMBP	Biological Products, (No Disgnostic Substances) (2836)	208097969

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1011938	Mark Steven Bathgate	5350 South Roslyn Suite 430 Greenwood Village CO 80111		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-06-27	10,000	$0.00	55,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants (Right to Buy)	Acquisiton	2011-06-27	10,000	$0.00	10,000	$2.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000	2011-06-27	2016-06-27	No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	604,000	Indirect	By wife
Common Stock	976,750	Indirect	By GVC Capital LLC
Common Stock	30,000	Indirect	By Bathgate Family Partnership Ltd.
Common Stock	50,000	Indirect	By daughter

Footnotes

The reporting person purchased 10,000 Units from the issuer in a private placement transaction for $1.25 per Unit. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of such securities for purposes of Section 16 or for any other purpose.